COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry - 1st Edition - ISBN: 9780128200452

The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry

1st Edition

Editor: Stephanie Ashenden
Paperback ISBN: 9780128200452
Imprint: Academic Press
Published Date: 1st May 2021
Page Count: 200
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


The Era of Artificial Intelligence, Machine Learning and Data Science in the Pharmaceutical Industry examines the drug discovery process, assessing how new technologies have improved effectiveness. Artificial intelligence and machine learning are considered the future for a wide range of disciplines and industries, including the pharmaceutical industry. In an environment where producing a single approved drug costs millions and takes many years of rigorous testing prior to its approval, reducing costs and time is of high interest. This book follows the journey that a drug company takes when producing a therapeutic, from the very beginning to ultimately benefitting a patient’s life.

This comprehensive resource will be useful to those working in the pharmaceutical industry, but will also be of interest to anyone doing research in chemical biology, computational chemistry, medicinal chemistry and bioinformatics.

Key Features

  • Demonstrates how the prediction of toxic effects is performed, how to reduce costs in testing compounds, and its use in animal research
  • Written by the industrial teams who are conducting the work, showcasing how the technology has improved and where it should be further improved
  • Targets materials for a better understanding of techniques from different disciplines, thus creating a complete guide


Academic and industrial researchers interested in drug discovery, chemical biology, computational chemistry, medicinal chemistry, and bioinformatics

Table of Contents

1. Introduction Drug Discovery
2. Intro to ML
3. Data Types
4. Target ID and Val
5. Hit Discovery
6. Lead Optimisation
7. Evaluating Safety and Toxicity
8. Precision Medicine and Finding the 'right patient': Date-driven Identification of Disease Subtypes
9. Image Analysis in Drug Discovery
10. Clinical Trials, Real World Evidence and Digital Medicine
11. To and From the Patient


No. of pages:
© Academic Press 2021
1st May 2021
Academic Press
Paperback ISBN:

About the Editor

Stephanie Ashenden

Dr. Ashenden is Senior Artificial Intelligence and Machine Learning Data Scientist at AstraZeneca, working in the Discovery Sciences, IMed-Biotech Unit. She received her PhD in 2018 from the Department of Chemistry, Cambridge University. Dr. Ashenden has three publications, but in very high impact resources (Methods in Enzymology, Journal of Chemical Information and Modeling, and Journal of Medicinal Chemistry). Dr. Ashenden is a very early career researcher, but has an extensive research network, academic and industrial experience, and a drive to conduct and report high quality research. She will be working with more experienced researchers on the project to help guide and offer experience.

Affiliations and Expertise

Senior Artificial Intelligence and Machine Learning Data Scientist, AstraZeneca

Ratings and Reviews